FGF19 and Other metabolic disease: Pharmacological activation of the FGF19 pathway has attractive therapeutic potential for treatment with metabolic disease and bile acid-related hepatobiliary disorders [16, 29], and in fact, FGF19 analogs are currently being tested in clinical trials.